Uncovering the Mechanism of Astragalus membranaceus in the Treatment of Diabetic Nephropathy Based on Network Pharmacology

Table 1

Basic information of AM compound ingredients.

Mol ID	Molecule name	OB (%)	DL
MOL000211	Mairin	55.38	0.78
MOL000239	Jaranol	50.83	0.29
MOL000296	Hederagenin	36.91	0.75
MOL000033	(3S,8S,9S,10R,13R,14S,17R)-10,13-Dimethyl-17-[(2R,5S)-5-propan-2-yloctan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol	36.23	0.78
MOL000354	Isorhamnetin	49.6	0.31
MOL000371	3,9-Di-O-methylnissolin	53.74	0.48
MOL000379	9,10-Dimethoxypterocarpan-3-O-β-D-glucoside	36.74	0.92
MOL000380	(6aR,11aR)-9,10-Dimethoxy-6a,11a-dihydro-6H-benzofurano[3,2-c]chromen-3-ol	64.26	0.42
MOL000387	Bifendate	31.1	0.67
MOL000392	Formononetin	69.67	0.21
MOL000398	7-O-methylisomucronulatol	74.69	0.3
MOL000417	Calycosin	47.75	0.24
MOL000422	Kaempferol	41.88	0.24
MOL000433	FA	68.96	0.71
MOL000442	1,7-Dihydroxy-3,9-dimethoxy pterocarpene	39.05	0.48
MOL000098	Quercetin	46.43	0.28